X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
New Fund Offer - ICICI Prudential Pharma Healthcare and Diagnostics Fund - Should You Invest? - Outside View by PersonalFN

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

New Fund Offer - ICICI Prudential Pharma Healthcare and Diagnostics Fund - Should You Invest?
Jul 6, 2018

An Open-Ended Equity Scheme following Pharma, Healthcare, Diagnostic and allied theme.

Scheme Details of ICICI Prudential Pharma Healthcare and Diagnostics Fund

Type An Open Ended Equity Scheme following Pharma, Healthcare, Diagnostic and allied theme Benchmark Index S&P BSE Healthcare Index
Min. Investment Min. Additional Investment Rs 5,000 and in multiples of Re 1 thereafter

Rs 1,000 and in multiples of Re 1 thereafter
Plans
  • Regular
  • Direct
Minimum SIP Application Amount Rs 1,000 and in multiples of Re 1 thereafter (Monthly SIP)

Rs 5,000 and in multiples of Re 1 thereafter (Quarterly SIP)
Options
  • Growth*
  • Dividend Pay-out
  • Dividend Reinvestment*
  • *default option
Minimum Redemption Amount Rs 500 or all units where amount is below Rs 500 Minimum Installment for SWP Rs 500 in multiples of Re 1 thereafter
Face Value Rs 10 per unit Exit Load 1% if redeemed or switched within 18 months from the date of allotment
Entry Load NA Expense Ratio Upto 3 %
Issue Opens 25-Jun-18 Issue Closes 9-Jul-18

Investment Objective of ICICI Prudential Pharma Healthcare and Diagnostics Fund

To generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.

However, there can be no assurance or guarantee that the investment objective of the scheme would be achieved.

*Source: Scheme Information Document

(Learn how to read the Scheme Information Document here.)

--- Advertisement ---
The Secret To Scoring Big With Small Caps Revealed…

Most people out there view small caps as a short-term thing.

In other words, they want to invest in small caps today, and get back huge returns in a few days to weeks.

But the best way to make triple- and probably even four-digit returns from small caps is to invest in solid small companies, and hold on to them for a fairly long time.

In fact, doing so has even given four-digit returns in the past.

To know how you can find solid small companies, just click here…
------------------------------

Is ICICI Prudential Pharma Healthcare and Diagnostics Fund for you?

ICICI Prudential Pharma Healthcare and Diagnostics Fund (IPPHDF) is an open-ended equity fund following pharma healthcare and allied theme.

Scheme's primary investment objective is long-term wealth creation. And to achieve this objective it aims to invest upto 100% of its net assets in equities of companies in pharma and allied sector.

As per the scheme mandate healthcare comprises of hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance and medical equipment.

Thematic Funds invest in stocks from one particular common theme. They are growth-oriented equity schemes that aim at capital appreciation by investing in a set of say 3-4 sectors that are closely related to one particular theme.

For example, healthcare funds will invest in equities of pharmaceutical companies, hospitals, diagnostics, wellness and so on.

Being a thematic fund, the fortune of the fund lies on the overall performance of the theme. Hence, consider your risk appetite before you invest. IPPHDF is a high-risk proposition like any other sector fund.

Hence, ICICI Prudential Pharma Healthcare and Diagnostics Fund is suitable only for investors with high risk appetite and investment horizon of more than 5 years.

Asset Allocation of ICICI Prudential Pharma Healthcare and Diagnostics Fund

The asset allocation of ICICI Prudential Bharat Consumption Fund under normal circumstances will be as under:

Instruments Indicative Allocation
(% of total assets)
Risk Profile
High/Medium/Low
Minimum Maximum
Equity & Equity related instruments of pharma, healthcare, diagnostics, wellness and allied companies. 80 100 High
Equity & Equity related instruments of other than pharma, healthcare, diagnostics, wellness and allied companies. 0 20 Medium To High
Debt, Units of Mutual Fund schemes, Money market instruments, Cash & Cash Equivalents 0 20 Low to Medium

The Scheme may also take exposure to:

  • Derivative instruments upto 50% of the Net assets of the Scheme
  • ADRs/ GDRs/ Foreign Securities/ Overseas ETFs upto 50% of Net assets of the Scheme
  • Securitized Debt upto 50% of debt portfolio
  • Stock Lending upto 20% of its Net assets. The Scheme shall also not lend more than 5% of its net assets to any counter party

(Source: Scheme Information Document)

Investment Strategy Of ICICI Prudential Pharma Healthcare and Diagnostics Fund

The proportion of investment between equity and debt will be decided based on the view of the fund manager on anticipated movement in both equity as well as debt markets. The Fund manager can also take aggressive calls on the market by going upto 100% in equity at any point of time or any other appropriate ratio depending upon his view.

The allocation between debt and equity will be decided based upon the prevailing market conditions, macro- economic environment the performance of the corporate sector, the equity market and other considerations.

Equity Asset Allocation

To achieve its primary objective of long-term capital appreciation the fund is mandated to invest 80% - 100% of its net assets into equity and equity related instruments of the healthcare theme. And around 0% - 20% of its net assets into equities other than healthcare theme.

The Scheme may invest in companies forming part of S&P BSE Healthcare Index or even stocks outside the index.

Debt Asset Allocation

The fund is mandated to invest 0 - 20% of its net assets into fixed income securities. The AMC aims to identify securities, which offer optimal levels of yield/return considering risk-reward ratio. An appropriate mix of debt and money market instruments will be used to achieve this.

Debt securities will be evaluated thoroughly in terms of credit risk by the risk management team of the AMC. The credit evaluation includes a study of the operating environment of the company, the past track record as well as the future prospects of the issuer, the short as well as long-term financial health of the issuer.

Fund Managers for ICICI Prudential Pharma Healthcare and Diagnostics Fund

ICICI Prudential Pharma Healthcare and Diagnostics Fund will be managed by Mr Ihab Dalwai and the overseas investments will be managed by Ms Priyanka Khandelwal.

Mr Ihab Dalwai is currently an Investment Analyst in MF Equity, sub - department of Investments. He is a Chartered Accountant and Graduate in Commerce. He has been associated with ICICI AMC since April 04, 2011.

Other Schemes managed by Mr Ihab are ICICI Prudential Multi-Asset Fund, ICICI Prudential Infrastructure Fund, ICICI Prudential Balanced Advantage Fund and ICICI Prudential Value Fund - Series 15.

Ms Priyanka Khandelwal is joint manager of this fund looking after the investments into foreign securities. She is a B. Com graduate, Chattered Accountant, Company Secretary and CFA - Level 1 cleared.

Other schemes managed by Ms Khandelwal are ICICI Prudential Global Stable Equity Fund, ICICI Prudential US Bluechip Equity Fund and also looks after investments for schemes which has a mandate to make overseas investments.

Fund Outlook of ICICI Prudential Pharma Healthcare and Diagnostics Fund

It is clear on evaluating the fund's objective and investment strategy that scheme will have exposure of upto 100% of its net assets into equity and equity related instruments in the healthcare and pharma sector.

The scheme aims to benefit from the pharma industry as whole. It aims to tap the benefit of the Indian Pharmaceuticals market which is the 3rd largest in terms of volume and 13th largest in terms of value. Furthermore healthcare has become one of India's largest sectors - both in terms of revenue and employment.

The scheme being theme specific will be largely affected by the risks associated with the pharma, healthcare, hospitals, diagnostics, wellness and allied sector.

Investment in the scheme carries the non-diversification risk of the portfolio due to the investment universe limited to theme. There could be instances when the portfolio might have an unusually high exposure to a few stocks.

Hence, stock selection within the sector will be limited. The portfolio construction will be concentrated, thereby giving the miss to the most important benefit of investing in MFs - Diversification.

Therefore, the fortune of the fund will be totally dependent on the performance of pharma, healthcare and diagnostics sector.

PersonalFN is a Mumbai based personal finance firm offering Financial Planning and Mutual Fund Research services.

Disclaimer:

The views mentioned above are of the author only. Data and charts, if used, in the article have been sourced from available information and have not been authenticated by any statutory authority. The author and Equitymaster do not claim it to be accurate nor accept any responsibility for the same. The views constitute only the opinions and do not constitute any guidelines or recommendation on any course of action to be followed by the reader. Please read the detailed Terms of Use of the web site.

Equitymaster requests your view! Post a comment on "New Fund Offer - ICICI Prudential Pharma Healthcare and Diagnostics Fund - Should You Invest?". Click here!

  

More Views on News

BSE Sensex at All Time High; ONGC Among Top Gainers (Market Updates)

Jul 18, 2018 | Updated on Jul 18, 2018

The BSE Sensex has hit an all-time high at 36,748 (up 0.5%) with ONGC among the top gainers.

Two Meetings That Nailed the Idea of Owning Brilliant Smallcaps Without Buying Them (The 5 Minute Wrapup)

Mar 22, 2018

Certain blue chips hold the potential of delivering returns comparable to small-cap stocks. With these stocks, you can get the best of both worlds.

What They Forgot to Tell You About Sensex at One Lakh (Profit Hunter)

Nov 29, 2017

Stocks that could beat Sensex returns in the long term.

Mere Paas HRITHIK Hai... The Mother of All Trading Stocks (Profit Hunter)

Jul 18, 2018

You are missing out big gains if you don't own these 8 stocks.

Donald Trump: Traitor? (Vivek Kaul's Diary)

Jul 18, 2018

Is Trump undermining the foundations of the Warfare State and the Police State? Is this a challenge to the power of the Deep State itself? Bill Bonner offers insights into the same.

More Views on News

Most Popular

How to Avoid a 90% Loss Suffered by This Super Investor(The 5 Minute Wrapup)

Jul 12, 2018

Blindly following super investors is a dangerous game to play. Here's how you can avoid such mistakes.

The Answer to Your Wealth Worries: Small Caps (Especially Now)(Profit Hunter)

Jul 10, 2018

If you're worried about the markets - you are on the wrong track. This is opportunity - put your wealth-building hat on, instead - Richa shows you how...

The Multiple Problems with the Minimum Support Price (MSP) System(Vivek Kaul's Diary)

Jul 11, 2018

The price signals that MSP sends out, creates its own set of problems.

New Fund Offer - ICICI Prudential Pharma Healthcare and Diagnostics Fund - Should You Invest?(Outside View)

Jul 6, 2018

ICICI AMC launches an open -ended equity fund following Pharma, Healthcare, Diagnostic and allied theme.

When Disappointment Panda is Around. Buy Quality Stock like This!(Chart Of The Day)

Jul 6, 2018

Buy Companies that can fight all kinds of Pandas and Bears in the long run.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

S&P BSE SENSEX


Jul 18, 2018 01:43 PM

MARKET STATS